Atlas FDA

HYALGAN

FDA premarket approval P950027/S009 · decided 2008-05-01

Approval details

PMA number
P950027
Supplement
S009
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
HYALGAN
Generic name
Acid, hyaluronic, intraarticular
Applicant
Fidia Farmaceutici S.P.A.
Date received
2007-06-20
Decision date
2008-05-01
Days to decision
316 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Abano Terme
Statement
APPROVAL FOR THE MODIFICATION OF THE MANUFACTURING PROCESS FOR HYALGAN FOR PRODUCING HYALURONATE BY A BACTERIAL FERMENTATION AND IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NONPHARMACOLOGIC THERAPY, AND TO SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HyaloGYN Vaginal Moisturizing Suppositories (K191052)Fidia Farmaceutici S.P.A.2020-01-09
HyaloGYN Vaginal Hydrating Gel (K150883)Fidia Farmaceutici S.P.A.2015-09-01
HYALO GYN (K094039)Fidia Farmaceutici S.P.A.2010-05-07